Early use of vericiguat for heart failure after heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if starting vericiguat early after a heart attack helps patients with heart failure. It's for people who had a procedure to open a blocked artery and then developed heart failure within two weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a procedure to open a blocked heart artery during your hospital stay.
- You developed heart failure within 14 days after your heart attack, with symptoms like shortness of breath or swelling, and needed water pills.
- Your heart's pumping strength is 45% or less, and your NT-proBNP level is high (≥1000 if normal rhythm, ≥1600 if atrial fibrillation).
- Your kidney function is good enough (eGFR at least 15).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a medication called vericiguat works in people with both chronic kidney disease and heart failure. It aims to see if the drug helps manage these conditions together.
This trial tests if adding the drug vericiguat to standard care can help people with heart failure and a reduced pumping ability who have a CardioMEMS monitor. It looks for improved pressure readings in your lung artery to guide treatment.
This trial tests whether vericiguat helps children with chronic heart failure caused by weaker left heart pumping. It also checks safety and how the medicine behaves in the body (dose and processing).
This study tests whether the heart failure medication vericiguat can also improve thinking and memory in people with heart failure who have mild cognitive problems. It involves taking vericiguat pills and having brain scans to track changes.
This trial studies whether starting an SGLT-2 inhibitor around the time of a heart attack can reduce heart damage size and improve how the heart heals. It focuses on people with a high risk of developing heart failure and who are getting a procedure to open blocked heart arteries.
This trial tests a medication called Vericiguat for people with heart failure and a weak heart pump after a past heart attack. It aims to see if the drug can help improve your condition.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.